PAMELA CLINARD: Open Payments
NPI 1649389412 · LEWISTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$200 in 3 payments from 3 companies in 2025. Trend: 2023 $35 · 2024 $0 · 2025 $200
Food & beverage: $200
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 1 | $150 |
| Celltrion USA Inc. | 1 | $25 |
| Boston Scientific Corporation | 1 | $25 |
Products named: REZDIFFRA, VEGZELMA, Autotome RX 49.
Industry payments across PA — which companies pay providers there.
